Harrow, Inc. (HROW)
30.89
-0.01
(-0.03%)
USD |
NASDAQ |
May 19, 15:02
Harrow EPS Diluted (TTM) : -0.4086 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Eli Lilly & Co. | 27.78 |
| Esperion Therapeutics, Inc. | -0.1034 |
| Theravance Biopharma, Inc. | 2.205 |
| Xeris Biopharma Holdings, Inc. | 0.0655 |
| Aquestive Therapeutics, Inc. | -0.603 |